Didanosine

Didanosine is a medicine used to treat HIV infection. It works by stopping the virus from making copies of itself. It's taken as a pill, usually with food.

Brand names:Videx
Medication

What people taking Didanosine report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Didanosine

What It's For

Didanosine, also called ddI and formerly sold under the brand names Videx and Videx EC, is an older antiviral medicine for HIV-1 infection. It was approved only for use together with other HIV medicines, as part of combination therapy that lowers the amount of virus in the blood. It does not cure HIV. Didanosine belongs to the nucleoside reverse transcriptase inhibitors, or NRTIs, one of the earliest classes of HIV medicine. Because it can seriously harm the pancreas, liver and nerves, it has been largely replaced by better tolerated medicines and is now rarely used. The US Food and Drug Administration (FDA) lists every didanosine product, brand and generic, as discontinued in the United States. Today the name comes up mainly in older treatment histories, which can still matter for future care.

How It Works

To multiply, HIV uses an enzyme called reverse transcriptase to copy its genetic material into DNA that can be built into the infected cell. Inside the body's cells, didanosine is converted into an active form that closely resembles one of the natural building blocks of DNA. The viral enzyme picks it up by mistake, and once it is added to the growing strand of viral DNA, the strand cannot be extended. Fewer new copies of the virus are made. HIV strains with reduced sensitivity to didanosine have been found in people taking it, which is part of why it was only ever used alongside other HIV medicines. Didanosine can also injure mitochondria, the energy-producing parts of human cells, and this is linked to several of its most serious side effects, including liver injury and lactic acidosis.

Dosage & Administration

The main form was a delayed-release capsule (Videx EC and generic versions) taken once a day on an empty stomach and swallowed whole, not opened or chewed. The dose was set by body weight and lowered for people with reduced kidney function, because the kidneys clear the drug. Children who could not swallow capsules used a liquid made from powder, taken 30 minutes before or 2 hours after eating. Buffered chewable tablets were an older form. If a dose was missed, the label advised taking it as soon as possible, unless the next dose was nearly due, in which case the missed dose was skipped. Because no didanosine product is currently marketed in the US, anyone who still has a supply or is offered it abroad should review the regimen with an HIV clinician rather than continuing or restarting it on their own.

Side Effects

Diarrhea, nausea, vomiting, headache and rash were among the most common effects in studies. Numbness, tingling or pain in the hands or feet is a characteristic problem. This is peripheral neuropathy, a form of nerve damage, and it is more likely in people with advanced HIV, earlier nerve damage, or who also take stavudine. It should be reported, because stopping didanosine may be necessary. Didanosine carries an FDA boxed warning, the agency's most serious label warning, for two dangers. The first is pancreatitis, inflammation of the pancreas, which has been fatal in some people. Stomach pain or swelling, nausea, vomiting or fever while taking didanosine calls for contacting the prescriber immediately. The second is lactic acidosis, a dangerous buildup of acid in the blood, often with a severely enlarged, fatty liver. Fast or difficult breathing, changes in heartbeat, extreme tiredness, cold or blue hands and feet, muscle pain, pain in the upper right abdomen, or yellowing of the skin or eyes call for contacting the prescriber immediately or getting emergency medical care. Less often, didanosine has caused changes in the retina and inflammation of the optic nerve, which can affect vision.

Interactions & Warnings

Didanosine must not be combined with allopurinol, a gout medicine, because it raises didanosine levels and toxicity. It must also not be combined with ribavirin, an antiviral used for hepatitis C, because the pair has caused fatal liver failure, pancreatitis and lactic acidosis. Taking it with stavudine, another older HIV medicine, raises the risk of pancreatitis, liver damage and severe nerve damage, and fatal lactic acidosis has occurred in pregnant women who took the two together. Adding hydroxyurea, a medicine used for some cancers and for sickle cell disease, should be avoided, because that combination has caused fatal liver damage. Tenofovir disoproxil fumarate, another HIV medicine, raises didanosine levels, so the didanosine dose had to be reduced and side effects watched closely. Methadone lowers didanosine levels. Other medicines that can inflame the pancreas or damage nerves add to its risks, and alcohol can make its toxicity worse. People with existing liver disease, including chronic hepatitis, have a higher chance of serious liver problems on didanosine. A history of pancreatitis, heavy drinking or kidney disease raises the risk of pancreatitis.

What to Expect

When didanosine was part of a working combination, the goal was the same as for any HIV regimen: bring the amount of virus in the blood down and keep it down, confirmed with regular viral load tests (blood tests that measure the amount of HIV). Monitoring also focused on its particular risks: symptoms of pancreatitis, nerve symptoms, liver test results and, where useful, periodic eye exams. One complication develops slowly. Non-cirrhotic portal hypertension is high pressure in the vein that carries blood to the liver, without the scarring of cirrhosis. With didanosine it has appeared months to years after starting, sometimes leading to bleeding veins in the esophagus, fluid in the abdomen, liver transplantation or death. Clinicians look for early clues during routine visits, such as a low platelet count or an enlarged spleen, and the medicine is stopped if the condition is found. Because safer HIV medicines are available, someone still taking didanosine would usually discuss a switch with their HIV clinician. Changes to an HIV regimen are best planned with that clinician rather than made alone, and a history of long-term didanosine use is worth mentioning when liver or spleen problems are being evaluated.

Questions to Ask Your Doctor

  1. 1.Is there any reason for me to stay on didanosine, and which current HIV medicine would replace it in my regimen?
  2. 2.How should we plan a switch so my viral load stays suppressed?
  3. 3.I took didanosine for a long time in the past. Should my liver, spleen or platelet count be checked for portal hypertension?
  4. 4.Could numbness or tingling in my hands or feet be related to didanosine, and what can help?

Last reviewed • Oct 2026

Educational content, not medical advice.